Capital Performance Advisors »

Lexicon Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $28 18 1.56

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
OrbiMed Advisors
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
NEA Management Company
State Street Corporation
Nantahala Capital Management
Schonfeld Strategic Advisors
Gail Mannix
Charles Schwab Investment Management
Point72 Asset Management
Woodline Partners

View all funds holding Lexicon Pharmaceuticals